Eric A. Voth
Research Subjects
Research Interests
Eric A. Voth has a total of 1 co-authors. Here are the top co-authors by number of shared publications:
Ernst Aeschbach
1 shared publication
Latest Publications
Prescription of heroin to treatment resistant heroin addicts
Footnotes Competing interests None declared
Prescription of heroin to treatment resistant heroin addicts
Footnotes Competing interests None declared
- 12 January 2004
- Published by Taylor & Francis in Journal of Addictive Diseases
- Vol. 22 (4) , 27-46
A Peek into Pandora's Box
The smoking of marijuana for medicinal applications is a volatile and difficult issue for the medical and regulatory communities which has reached the forefront of discussions of public policy. Any consideration of this issue must take into account the substantial toxicity, impurity, and morbidity associated with marijuana use. Several states have passed ballot initiatives or legislation that allow a medical excuse for possession of marijuana. These initiatives bypass the Food and Drug Administration process of proving safety and efficacy, and they have created serious regulatory dilemmas for state regulatory boards. Several examinations of the issue have consistently drawn question to the validity of smoking an impure substance while voicing concern for the well being of patients in need. The historical, social, medical, and legal issues are examined.
- 12 January 2004
- Published by Taylor & Francis in Journal of Addictive Diseases
- Vol. 22 (4) , 27-46
A Peek into Pandora's Box
The smoking of marijuana for medicinal applications is a volatile and difficult issue for the medical and regulatory communities which has reached the forefront of discussions of public policy. Any consideration of this issue must take into account the substantial toxicity, impurity, and morbidity associated with marijuana use. Several states have passed ballot initiatives or legislation that allow a medical excuse for possession of marijuana. These initiatives bypass the Food and Drug Administration process of proving safety and efficacy, and they have created serious regulatory dilemmas for state regulatory boards. Several examinations of the issue have consistently drawn question to the validity of smoking an impure substance while voicing concern for the well being of patients in need. The historical, social, medical, and legal issues are examined.
- 1 March 2002
- Vol. 176 (2) , 77
Should physicians support the medical use of marijuana? No: evidence of its safety and efficacy is weak. Counterpoint.
- 1 March 2002
- Vol. 176 (2) , 77
Should physicians support the medical use of marijuana? No: evidence of its safety and efficacy is weak. Counterpoint.
- 1 November 2001
- Published by BMJ in Western Journal of Medicine
- Vol. 175 (5) , 305-306
Guidelines for prescribing medical marijuana
- 1 November 2001
- Published by BMJ in Western Journal of Medicine
- Vol. 175 (5) , 305-306
Guidelines for prescribing medical marijuana